Search clinical trials for: Tamper-resistant formulation

Total 2751 results

Allergan

Completed

Safety and Efficacy Study of Different Formulations of Bimatoprost Once-Daily in Patients With Glaucoma or Ocular Hypertension

Ocular Hypertension | Glaucoma

United States
Mylan Pharmaceuticals Inc

Completed

Evaluation of Adhesion Quality of a New Formulation of the Mylan Estradiol Transdermal System 0.025 mg/Day and Climara® Transdermal System 0.025 mg/Day

Healthy

United States
Aeris Therapeutics

Terminated

Israeli 10 mL Bronchoscopic Lung Volume Reduction (BLVR) Phase 1/2 Emphysema Study - Initial Formulation

Pulmonary Emphysema

Israel
NeurogesX

Completed

Study of Three Capsaicin Dermal Liquid Formulations on Epidermal Nerve Fiber Immunostaining and Sensory Function

Pain
Aeris Therapeutics

Completed

US 10 mL Bronchoscopic Lung Volume Reduction (BLVR) Phase 1 Emphysema Study - Initial Formulation

Pulmonary Emphysema

United States
Biolipox AB

Completed

Taste and Local Tolerance Study of NLA Nasal Spray in Patients With Allergic Rhinitis

Allergic Rhinitis

Sweden
National Eye Institute (NEI)

Completed

New Cysteamine Eye Drops Formulation to Treat Corneal Crystals in Cystinosis

Cystinosis

United States
Eunice Kennedy Shriver National Institute of Child...

Completed

Comparison of Blood Levels of Two Formulations of the Selective Hormone Receptor Modulator CDB-2914

Healthy

United States
Hellenic Cooperative Oncology Group
University of Ioannina

Completed

Metronomic Oral Vinorelbine in Patients With Metastatic Tumors

Breast Cancer | Prostate Cancer | Non Small Cell Lung Cancer

Greece
B. Braun Melsungen AG
Tigermed Consulting Co., Ltd; B. Braun Medical International Trading Company...

Completed

Efficacy and Safety Study of Two Propofol Formulations

General Anaesthesia | Induction of Anaesthesia

China
Solvay Pharmaceuticals

Completed

Analgesic Effectiveness of Three Different Doses of a New Formulation of Lamaline in a Model of Painful Knee (Gonarthrosis)

Knee Osteoarthritis

France
BioPartners GmbH
LG Life Sciences

Completed

Sustained Release Formulation of Somatropin (rDNA Origin)for Injection

Growth Hormone Deficiency
Dafra Pharma
Kenya Medical Research Institute

Completed

Randomised Efficacy Study of Two Artemether-Lumefantrine Oral Formulations for the Treatment of Uncomplicated P. Falciparum Malaria

Malaria, Falciparum

Kenya
NeurogesX

Completed

Tolerability of Three Local Anesthetic Formulations in Conjunction With NGX-4010 for the Treatment of Neuropathic Pain

HIV Infections | Pain | Diabetes Mellitus | Diabetic Neuropathies | Peripheral Nervous System Diseases | Neuralgia | Herpes Zoster | Polyneuropathies

United States
Braintree Laboratories

Completed

A Safety and Efficacy Evaluation of 3 Bowel Preparations in the Pediatric Population

Colonoscopy

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating 3 New Formulations of SKI-606 in Healthy Adult Subjects

Healthy

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Comparing Formulations of Bazedoxifene/Conjugated Estrogens

Healthy
MediQuest Therapeutics

Completed

Dose Response Study of a Topical Formulation of Nitroglycerin for the Treatment of Raynaud's Phenomenon

Raynaud's Disease

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Comparing Bioavailability of 3 New Formulations of Premarin/MPA With Premarin/MPA (PREMPRO) Reference Formulation

Estrogen Replacement Therapy
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Bioequivalence Study of 3 New Formulations of Premarin/MPA Compared With Premarin/MPA (Prempro)

Postmenopause

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating of Recombinant Human Factor IX (BeneFIX) and a New Formulation of BeneFIX (rFIX-R) in Moderate to Severe Hemophilia B

Hemophilia B
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Comparing Bioavailability of Oral Formulations of Vabicaserin

Schizophrenia

United States
Grupo Portugues de Estudo do Cancro do Pulmao

Unknown

Efficacy and Safety of Cetuximab in Combination With Cisplatin Gemcitabine as First-Line Therapy in Advanced NSCLC (Coimbra)

Carcinoma, Non-Small-Cell Lung

Portugal
Grünenthal GmbH

Terminated

Single Dose Trial Comparing the Plasma Levels of Two Different Analgesic Transdermal Patch Formulations (Protocol ID 297307)

Healthy

Germany
Grünenthal GmbH

Terminated

Multiple Dose Trial Comparing the Plasma Levels of Two Different Analgesic Transdermal Patch Formulations (Protocol ID: 855509)

Healthy

Germany
Novartis

Completed

Famciclovir Oral Pediatric Formulation in Children 1-12 Years of Age With Varicella Zoster Infection

Herpes Zoster | Chickenpox

United States, Costa Rica, Guatemala, Panama
QualiLife Pharmaceuticals

Completed

Zestra in Women With Mixed Sexual Dysfunction

Sexual Dysfunction, Psychological

United States
Grünenthal GmbH

Terminated

Single Dose Trial Comparing the Plasma Levels of Two Different Analgesic Transdermal Patch Formulations

Healthy

Germany
Novartis

Completed

To Compare the Blood Level of Marketed Japanese Valsartan Tablet Formulation vs Global Valsartan Tablet Formulation in Healthy Volunteers

Healthy

India
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Comparing Bioequivalence of Two New Formulations of Premarin/MPA With Premarin/MPA Reference Formulation.

Postmenopause | Postmenopausal Osteoporosis
MediQuest Therapeutics

Completed

Phase III Study of a Topical Gel Formulation for Treatment and Prevention of Raynaud's Phenomenon

Autoimmune Diseases | Scleroderma | Raynaud's Disease

United States, United Kingdom, Sweden
Grupo de Investigacao do Cancro Digestivo

Unknown

XELOX Plus Cetuximab as First-Line Therapy in Patients With Metastatic Colorectal Cancer

Colorectal Carcinoma

Portugal
Institute of Child Health

Completed

Pain of Injection of Lipuro Propofol in Children Aged 1-7 Years

ASA 1-2 Requiring Intravenous Cannulation for General Anaesthesia

United Kingdom
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Comparing 2 Different Formulations of Pantoprazole in Healthy Adults.

Healthy Subjects
POZEN

Completed

The Safety Of Combo Formulation In The Treatment Of Multiple Episodes Of Acute Migraine Over 12 Months

Migraine Headaches

United States
Altus Pharmaceuticals

Completed

Study of an Extended-Release, Crystalline Formulation of Recombinant Human Growth Hormone (ALTU-238) in Growth Hormone Deficient Adults to Determine Pharmacokinetics, Pharmacodynamics, and Drug Safety

Adult Growth Hormone Deficiency

United States
GlaxoSmithKline

Completed

Assess Immune Response Following Primary Vaccination With Tritanrix™-HepB Vaccine Mixed With 3 Formulations of Hib-MenAC Vaccine to Infants

Hepatitis B | Pertussis | Tetanus | Diphtheria | Hib Diseases | Neisseria Meningitidis Serogroups A & C Diseases

Philippines
International Vaccine Institute
Göteborg University; National Institute of Hygiene and Epidemiology, Vietnam

Completed

Safety and Immunogenicity of a New Formulation of a Bivalent Killed, Whole-Cell Oral Cholera Vaccine

Cholera

Vietnam
MedImmune LLC
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Trial to Compare the Safety, Tolerability, Immunogenicity and Efficacy of Three Dose Levels of a Liquid Formulation of Influenza Virus Vaccine, (CAIV-T) in Healthy Children

Healthy

Philippines, Thailand
MedImmune LLC
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Trial to Assess the Safety and Tolerability of the Liquid Formulation of CAIV-T in Healthy Children.

Healthy
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Comparing Four New Formulations for Premarin in Healthy Postmenopausal Women

Postmenopause
Astellas Pharma Inc

Completed

A Study to Assess the Safety and Efficacy of a Tacrolimus New Oral Formulation (MR4) in BMT Patients-Extension-

Bone Marrow Transplantation | Graft Versus Host Disease | Graft-Versus-Host Disease | Graft-Vs-Host Disease

Japan
IBSA Institut Biochimique SA

Completed

Endometrial Effects of Daily Progesterone s.c. 25 and 50 Mg Aqueous Formulation to Female Healthy Volunteers

Healthy
Lampiris, Harry W., M.D.
Abbott

Unknown

High Dose Ritonavir/Lopinavir Liquid Formulation in Salvage Therapy for Protease Inhibitor Resistant HIV Disease

HIV | AIDS

United States
Astellas Pharma Inc

Completed

A Study to Assess Efficacy, Safety and Pharmacokinetics of a Tacrolimus New Oral Formulation (MR4) in BMT Recipients

Bone Marrow Transplantation | Graft Versus Host Disease | Graft-Versus-Host Disease | Graft-Vs-Host Disease

Japan
Novartis
Novartis Vaccines

Completed

Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2006/2007) When Administered to Subjects 18 Years of Age or Older

Influenza

Italy
Novartis
Novartis Vaccines

Completed

Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2006/2007) When Administered to Elderly Subjects

Influenza

Italy
National Institute on Drug Abuse (NIDA)

Completed

Study Comparing Liquid and Tablet Buprenorphine Formulations - 5

Heroin Dependence

United States
Biosyn
National Institute of Allergy and Infectious Diseases (NIAID)

Unknown

An Imaging Trial of the Distribution of Topical Gel Formulations in the Human Vagina

HIV Infections

United States
Hoffmann-La Roche

Completed

A Randomized, Parallel Arm, Comparative, Open Label, Multicenter Study of the Activity and Safety of Two Formulations of Saquinavir in Combination With Other Antiretroviral Drugs

HIV Infections

Canada, United States

3

Subscribe